glp-1 novo Nordisk plans to slash prices Novo, Lilly weight-loss drugs should

Description

Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug

Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al

RESULT Adherence to GLP-1 receptor agonists was 84% at 6 months

"With its immunoglobulin levels, ability to actually help heal a condition called leaky-gut and offer enhanced growth and immune support it is one to watch." Sankarlal also points to fiber-fortified dairy as an area with strong potential

You'll likely see your healthcare provider for regular check-ups to make sure the drug is working, monitor for possible side effects, and make dosing adjustments as needed